Restless legs syndrome in the elderly: An unrecognized disorder;Syndrome des jambes sans repos chez la personne âgée: Une affection méconnue

Revue Medicale Suisse

Volumn 4, Issue 178, 2008, Pages 2382-2386

  Biselx, Stéphane ^a,c,d   Büla, Christophe ^c,d   Ghika, Joseph ^b,c  

^a Réseau Santé Valais   (Switzerland)

^b Service de Neurologie   (Switzerland)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d CUTR Sylvana   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CODEINE; GABAPENTIN; LEVODOPA; METHADONE; MORPHINE; OXYCODONE; TOPIRAMATE; TRAMADOL; VALPROIC ACID;

AGED; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; COGNITIVE DEFECT; DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; POLYSOMNOGRAPHY; QUALITY OF LIFE; RESTLESS LEGS SYNDROME; REVIEW; SLEEP;

AGED, 80 AND OVER; ALZHEIMER DISEASE; AMINES; ANTICONVULSANTS; BENZODIAZEPINES; CYCLOHEXANECARBOXYLIC ACIDS; DIAGNOSIS, DIFFERENTIAL; DOPAMINE AGENTS; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; NARCOTICS; QUALITY OF LIFE; RESTLESS LEGS SYNDROME; SLEEP DISORDERS; TRANQUILIZING AGENTS;

EID: 56349161602     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (14)

1. Hening W, Walters AS, Allen RP, et al. Impact, diagnosis and treatment of restless legs syndrome in a primary care population: The REST (RLS epidemiology, symptoms, and treatment) primary care study. Sleep Med 2004;5:237-46.
2. Sforza E, Cervena K. Syndrome des jambes sans repos et traitement psychiatrique. Rev Med Suisse 2006; 2:2108-14.
3. Allen RP, Walters AS, Montplaisr J, et al. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med 2005;165:1286-92.
4. Cuellar N, Strumpf N, Ratcliffe S. Symptoms of Restless legs syndrome in older adults: Outcomes on sleep quality, sleepiness, fatigue, depression and quality of life. JAGS 2007;55:1387-92.
5. Allen RP, Picchietti D, Hening WA, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National institute of health. Sleep Med 2003:4:101-19.
6. Montplaisir J, Boucher S, Poirier G, et al. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome:A study of 133 patients diagnosed with new standard criteria. Mov Disord 1997;12:61-5.
7. Phillips B, Youg T, Finn L, et al. Epidemiology of restless legs symptoms in adults. Arch Intern Med 2000;160:2137-41.
8. O'Keeffe ST, Gavin K, Lavan JN. Iron status and restless legs syndrome in the elderly. Age Ageing 1994;23:200-3.
9. Merlino G, Fratticci L, Valente M, et al. Association of restless legs syndrome in type 2 diabetes: A case-control study. Sleep 2007;30:866-71.
10. Gomez-Esteban J, Zarranz J, Tijero B, et al. Restless legs syndrome in Parkinson's disease. Mov Disord 2007;13:1912-6.
11. Silber M, Ehrenberg B, Allen R, et al. An algorithm for the management of restless legs syndrome. Mayo Clin Proc 2004;79:916-22.
12. Amateis C, Büla C. Insomnies chez les personnes âgées: quelle approche? Rev Med Suisse 2007;3:2537-41.
13. Hening WA, Allen RP, Earley C, et al. An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. Restless legs syndrome task force of the standards of practice committee of the American academy of sleep medicine. Sleep 2004;27:560-83.
14. Paulus W, Trenkwalder C. Less is more: Pathophysiology of dopaminergic-therapy-related augmentation in restless legs syndrome. Lancet Neurol 2006;5:878-86.